Several leading classes of therapies are exploring diverse mechanisms of action to treat CHF, including SGLT2 inhibitors, cardiac myosin activators, myeloperoxidase inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, cell therapies, and more. This growing focus is…

The high and growing incidence of tuberculosis (TB) cases globally, especially in high-burden countries, is a major driver for both the treatment drugs and diagnostics markets. TB remains a significant public health challenge, with millions of new cases reported each year, particularly in…

LONDON and NEW YORK and MUMBAI, India, Jan. 22, 2025 /PRNewswire/ — BancTrust Investment Bank (BancTrust), a leader in Emerging Markets investment banking, is pleased to announce its strategic partnership with the Anand Rathi Group, one of India’s most respected and research-driven…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.